João A. Oliveira‐da‐Silva

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection

Daniela P. Lage, Patrícia A.F. Ribeiro, Daniel Dias et al. · npj Vaccines · 2020 · 51 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Detecting anti–SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion

Fernanda Ludolf, Fernanda F. Ramos, Flávia Fonseca Bagno et al. · Science Advances · 2022 · 35 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A clioquinol-containing Pluronic^® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model

Grasiele S.V. Tavares, Débora V.C. Mendonça, Isabela A.G. Pereira et al. · Parasite · 2020 · 30 citations · Full text

Veterinary Medicine, Infectious Diseases, Medicinal Chemistry +16

Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans

Thaís T.O. Santos, Mariana Santos Cardoso, Amanda S. Machado et al. · Microbial Pathogenesis · 2019 · 29 citations

Veterinary Medicine, Infectious Diseases, Veterinary Parasitology +13

A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection

Daniela P. Lage, Danniele L. Vale, Flávia P. Linhares et al. · Vaccines · 2022 · 29 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17